<DOC>
	<DOCNO>NCT02112903</DOCNO>
	<brief_summary>The purpose study evaluate gastro-intestinal tolerability ( nausea , vomit , diarrhoea , abdominal discomfort , abdominal pain ) vortioxetine follow single oral dos three modified-release ( MR ) capsule differently coat multiple particle compare one immediate-release ( IR ) tablet .</brief_summary>
	<brief_title>Study Comparing Gastro-intestinal Tolerability Absorption Profile Vortioxetine After Administration Modified-release Formulations Immediate-release Formulation Healthy Women</brief_title>
	<detailed_description />
	<mesh_term>Vortioxetine</mesh_term>
	<criteria>Healthy woman ≥18 ≤45 year age body mass index ( BMI ) &gt; 18.5 &lt; 30.0 kg/m2 . Women childbearing potential confirm nonpregnant nonlactating status . Other protocoldefined Inclusion Exclusion Criteria may apply .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>